EDGAR Filing Documents for 0001104659-22-004479

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001104659-22-004479

Filing Date

2022-01-14

Accepted

2022-01-14 17:13:40

Documents

158

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F/A	calt-20201231x20fa.htm iXBRL	20-F/A	364790
2	EXHIBIT 12.1	calt-20201231xex12d1.htm	EX-12.1	10847
3	EXHIBIT 12.2	calt-20201231xex12d2.htm	EX-12.2	10680
4	EXHIBIT 13.1	calt-20201231xex13d1.htm	EX-13.1	7567
5	EXHIBIT 13.2	calt-20201231xex13d2.htm	EX-13.2	6855
6	EXHIBIT 15.1	calt-20201231xex151.htm iXBRL	EX-15.1	2866257
7	EXHIBIT 15.3	calt-20201231xex15d3.htm	EX-15.3	3766
	Complete submission text file	0001104659-22-004479.txt		17385159

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	calt-20201231.xsd	EX-101.SCH	158672
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	calt-20201231_cal.xml	EX-101.CAL	106431
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	calt-20201231_def.xml	EX-101.DEF	464657
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	calt-20201231_lab.xml	EX-101.LAB	991595
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	calt-20201231_pre.xml	EX-101.PRE	820169
152	EXTRACTED XBRL INSTANCE DOCUMENT	calt-20201231x20fa_htm.xml	XML	4375330

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22

Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005

Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)